This makes the adult-onset DM1 and EDM1 mouse models, which have robust multi-systemic phenotypes and utilize the doxycycline inducible EGFP DMPK 3′UTR, a useful model to test many of the ever increasing number of therapeutic options aimed at treating myotonic dystrophy. Here, DMPK is linked to myotonic dystrophy.